Central Vein Sign in Multiple Sclerosis Study
Central Vein Sign in Multiple Sclerosis Extension Study
Recruiting
N/A
Interventional Study
Multiple Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 40 (estimated)
- Sponsor
- The Cleveland Clinic · Other
Who this trial is looking for
This trial is looking for people who are already part of the CAVS-MS study and have completed their 24-month visits. Participants will be followed for 48 months to see how two specific MRI markers help in diagnosing and monitoring multiple sclerosis.
Are You a Good Fit for This Trial?
You may be able to join if
- I am enrolled in the CAVS-MS study.
- I have completed my month 24 visits.
- I can provide written informed consent.
You may not be able to join if
- I cannot have an MRI due to metal implants.
- I cannot tolerate an MRI because of claustrophobia.
- I have excessive movement that prevents me from having an MRI.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Multiple sclerosis (MS) is a common disease of the central nervous system that affects almost 1 million people in the United States. However, diagnosing MS can be difficult and often leads to misdiagnosis. More sensitive and specific biomarkers are needed to help with the diagnosis, prognosis, and evaluation of treatment response for MS. The central vein sign (CVS) and the paramagnetic rim lesion …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants must be enrolled in and meet all inclusion criteria of the CAVS-MS study.
* Must have participated in the CAVS-MS study and have completed month 24 visits.
* Able to provide written informed consent to participate in the study.
Exclusion Criteria:
* Contraindica…
Contacts